Bipolar Disorders: forecast patient populations for type I and type II variations.
As with other psychiatric disorders, the epidemiology of bipolar disorder has historically been poorly described due to variations in diagnostic methods, evolving disease definitions, and stigma surrounding the disorder. The total number of prevalent cases of type I and type II bipolar disorder is estimated to increase to approximately 7.7 million cases across the US, Japan, and five major EU markets by 2033.
Datamonitor Healthcare has used high quality data sources to forecast bipolar disorder patient populations for both type I and type II variations of the disease.
How will our bipolar disorder epidemiology report benefit you?
- Gain expert knowledge
Access an up-to-date overview of the definition and diagnosis of bipolar disorder, allowing you to gain a better understanding of the disease and the challenges within it.
- Identify potential market
Explore detailed forecasts of prevalent cases of type I and type II diagnosed bipolar disorder, segmented by age and gender, enabling you to identify your target population and any challenges in terms of reaching them.
- Explore potential challenges
Identify three psychiatric co-morbidities associated with type I and type II bipolar disorder and the size of the affected populations, allowing you to identify any unmet needs or problems you may face with your product.
Key questions answered
- What are the challenges to understanding and defining bipolar disorder?
- What are the latest known risk factors for bipolar disorder?
- What amount of market share does each age group account for within the bipolar disorder patient population?
- How does the type I patient population compare to that of type II?